Emerging evidence supports the use of psilocybin in palliative care, yet Schedule I status uniquely limits access outside of clinical trials in the US.
Kristin Speer, PharmD, BCPS, RPh
Advertisement
Articles by Kristin Speer, PharmD, BCPS, RPh
Engagement and recognition of pharmacist expertise grows as state psychedelic bills expand.
Advertisement
Latest Updated Articles
Pathways to Psilocybin in Palliative CareMay 14th 2026
Advertisement
Advertisement
Trending on Pharmacy Times
1
Preparing Pharmacists for Psychedelic Medicine
2
Pneumonic Plague: What Pharmacists Need to Know About Treatment
3
Beyond Skin Clearance: What Litifilimab Could Mean for Cutaneous Lupus Care
4
FDA Approves Pritelivir for Refractory HSV Lesions in Immunocompromised Adults
5